MedShadow.org is dedicated to empowering people with our evidence-based journalism about the safest ways to take over-the-counter (OTC) and prescription (Rx) medications.
We also seek to stimulate public discussion about potential improvements to drug research, manufacturing and distribution processes. and also to encourage the improvement of processes to ensure that we are all better protected.
As a result, we encourage other nonprofit newsrooms, mission-aligned outlets, and advocacy organizations to republish our original content under the following conditions:
1. We Are Credited Fully and Clearly
You must include the byline and credit MedShadow.org as the original publisher. Please include a link to the original article at the top or bottom of the piece. Use the following attribution:
This article was originally published by MedShadow, a nonprofit foundation that focuses on the safest ways to take over-the-counter and prescription medications.
2. Our Content Isn’t Edited Without Permission
You may make small changes for clarity, such as adjusting headlines, subheadings, or transitions, but you may not change the core meaning, tone, or intent of the article. For substantive edits, email us at republish@medshadow.org for review and approval.
3. You Do Not Sell Or Use Our Content Commercially
Our work is free to share, but it may not be sold, monetized, or repurposed for commercial gain. You may not republish our articles behind a paywall or in publications whose primary purpose is advertising or product promotion. You may not place drug or supplement advertising adjacent to our story.
4. Photos, Graphics, and Multimedia Are Not Used Without Permission
Only the text of the article is available for republication. Images, graphics, and videos may not be reused without explicit written permission, unless they are clearly marked as Creative Commons licensed. Contact us if you’d like to request reuse of a visual asset.
If you’re unsure whether your intended use falls within these guidelines, or would like to discuss a formal syndication or licensing arrangement, please email: republish@medshadow.org
We want our journalism to reach as many people as possible, especially those making critical decisions about medications and health.
<!-- wp:paragraph --> <p>If you experience frequent heartburn, you’ve likely considered taking an over-the-counter proton-pump inhibitor (PPI) like <a href="https://medlineplus.gov/druginfo/meds/a693050.html" target="_blank" rel="noreferrer noopener">omeprazole</a> (brand names include Prilosec OTC and Zegerid OTC). Some research suggests that PPIs can reduce the body’s absorption of <a href="https://medlineplus.gov/druginfo/meds/a682461.html" target="_blank" rel="noreferrer noopener">levothyroxine</a>, a synthetic hormone commonly prescribed when blood thyroid hormone levels are too low. But experts say this potential interaction shouldn’t be a concern for people taking a non-prescription PPI for a short period of time.</p> <!-- /wp:paragraph --><!-- wp:heading --> <h2 class="wp-block-heading">Omeprazole and Levothyroxine Interactions: Minimal Short-Term Effects</h2> <!-- /wp:heading --><!-- wp:paragraph --> <p>PPIs lower gastric acid levels by blocking acid-producing enzymes in the stomach lining. Over-the-counter PPIs, such as omeprazole, <a href="https://www.statpearls.com/point-of-care/search?q=Esomeprazole" target="_blank" rel="noreferrer noopener">esomeprazole</a> (Nexium 24HR), and <a href="https://www.nhs.uk/medicines/lansoprazole/" target="_blank" rel="noreferrer noopener">lansoprazole</a> (Prevacid 24HR), can be taken for 14 days up to three times per year. Side effects are uncommon, but they may include headaches, nausea, vomiting, diarrhea, constipation and gas. <a href="https://medshadow.org/ppis-heartburn-drugs-side-effects-dementia/" target="_blank" rel="noreferrer noopener">Long-term use of PPIs has been linked with an increased risk of several medical conditions</a>, including kidney disease, infections and bone loss.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>Typically taken as a tablet, levothyroxine replaces the body’s thyroid hormone in individuals with deficiency, which can be caused by the autoimmune disorder <a href="https://www.ncbi.nlm.nih.gov/books/NBK459262/" target="_blank" rel="noreferrer noopener">Hashimoto thyroiditis</a>, surgical removal of the thyroid, or other conditions.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>Levothyroxine tablets dissolve in the stomach before being absorbed in the small intestine. Since PPIs suppress stomach acid, researchers have questioned whether they might reduce the absorption of levothyroxine. However, while a few clinical studies <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8175524/" target="_blank" rel="noreferrer noopener">have reported small changes in thyroid levels</a> in participants with hypothyroidism on who are on thyroid replacement therapy while taking PPIs, a clear connection has not been firmly established.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>“A lot of the studies that have looked at this are very small, so it’s hard to make a definitive statement,” notes <a href="https://nyulangone.org/doctors/1669632196/rachel-pessah-pollack" target="_blank" rel="noreferrer noopener">Rachel Pessah-Pollack, M.D.</a>, an endocrinologist at NYU Langone Health.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>Any interference with absorption is unlikely to be clinically significant for people taking a short course of an over-the-counter PPI, continues <a href="https://pharmacy.umich.edu/people/regal-randolph/" target="_blank" rel="noreferrer noopener">Randolph Regal, Pharm.D.</a>, meaning it would not necessitate a change to the person’s thyroid treatment. Dr. Regal, a clinical pharmacist specializing in internal medicine at the University of Michigan, explains that levothyroxine has a <a href="https://www.ncbi.nlm.nih.gov/books/NBK554498/" target="_blank" rel="noreferrer noopener">half-life</a> of about a week. This means that it takes at least one month (four half-lives) for levels of the hormone to stabilize in the body following a change. Thus, a minor reduction in levothyroxine absorption over a short period is unlikely to have a lasting effect.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>Since food can interfere with levothyroxine absorption, it’s recommended to take the drug at least 30 to 60 minutes before breakfast. Dr. Pessah-Pollack suggests taking a PPI three to four hours after levothyroxine to minimize potential interactions, but acknowledges that some people find it easier to take both medications at the same time.</p> <!-- /wp:paragraph --><!-- wp:heading --> <h2 class="wp-block-heading">What Are Alternatives to Omeprazole?</h2> <!-- /wp:heading --><!-- wp:paragraph --> <p>H2 blockers like <a href="https://medlineplus.gov/druginfo/meds/a687011.html" target="_blank" rel="noreferrer noopener">famotidine</a>, available over-the-counter and by prescription, are shorter-acting acid reducers that provide more immediate symptom relief than PPIs. Diet and lifestyle changes, such as sitting upright after eating and avoiding spicy foods, can also reduce reflux symptoms, says Dr. Pessah-Pollack.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>However, people with severe reflux are more likely to require prescription PPIs. If you start using a long-term PPI, it’s important to tell your thyroid care provider, notes Boston Medical Center endocrinologist <a href="https://www.bmc.org/about-us/directory/doctor/elizabeth-n-pearce-md" target="_blank" rel="noreferrer noopener">Elizabeth Pearce, M.D.</a> Individuals taking PPIs continually may need to be on a higher dose of levothyroxine.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>For those individuals who need to take both medications, switching to liquid levothyroxine (Tirosint-SOL) may be an alternative, since <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/december-2024/vol-17-issue-12-p-10-11/?utm_source=chatgpt.com" target="_blank" rel="noreferrer noopener">it does not rely on stomach acid</a> for absorption and <a href="https://www.businesswire.com/news/home/20231204748430/en/Food-And-Drug-Administration-Grants-Two-New-Label-Changes-To-Tirosint-Sol-Levothyroxine-Sodium-Oral-Solution" target="_blank" rel="noreferrer noopener">has not been shown</a> to interact with PPIs. The drawback is that the liquid formulation is often more costly than generic tablets.</p> <!-- /wp:paragraph --><!-- wp:paragraph --> <p>If you’re dealing with ongoing heartburn — whether or not you take thyroid medication — it’s always a good idea to work with your doctor to find the cause, rather than depending on symptom-relieving drugs alone.</p> <!-- /wp:paragraph -->
No comments yet. Be the first to comment!